ESR1 and breast carcinoma: Interestingly, He et al. (2013) reported that miR-342 expression is positively correlated with ERα expression in clinical breast cancer samples and breast cancer cell lines, which is proposed as a potential mechanism of enhanced tamoxifen sensitivity in breast cancer cell lines with ectopic miR-342 overexpression [92].